Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer 7 February 2024 | Press release
New Approaches for Cancer Therapies: Targeting the DNA Damage Response 27 January 2024 | Uncategorised
Professor Sir Stephen Jackson receives a knighthood for services to innovation and research 19 June 2023 | Announcement
EACR-AACR Immune Response and DNA Repair Cancer Fields Converging Conference 23 March 2023 | Conferences
Graeme Smith, CSO and Helen Robinson, VP Biology attending the 5th Digital DDR, ATR, & PARP Summit – 25/26 January 2022 25 January 2022 | Conferences
Listen to our CEO and CSO talk at the Northland Synthetic Lethality Conference – Nov 17 2021 2 December 2021 | Conferences
Niall Martin, Chief Executive Officer presented a company overview at LifeSci Partners Precision Oncology Day 17 February 2021 | Conferences